MD / MS / DNB · MD Pharmacology

Drug development

Read the topic background here, then explore the labeled visual and structured learning explanations on this page.

Read explanation on this page ↓ See diagram ↓
Read here · Topic background

Drug development — on-site reading

An introductory overview for this topic. The article introduction is reproduced here, so you do not need to leave MedAtlas to read it. It may not match the latest official medical guidance.

Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery. It includes preclinical research on microorganisms and animals, filing for regulatory status, such as via the United States Food and Drug Administration for an investigational new drug to initiate clinical trials on humans, and may include the step of obtaining regulatory approval with a new drug application to market the drug. The entire process—from concept through preclinical testing in the laboratory to clinical trial development, including Phase I–III trials—to approved vaccine or drug typically takes more than a decade.

How this connects to MD Pharmacology

Paediatric assessment is age-dependent: anatomy, expected vital signs, immune function, nutrition and development change rapidly from infancy to adolescence. Interpretation requires gestational or chronological age, growth trajectory, caregiver history and appropriate pediatric reference standards.

Text credit: Wikipedia contributors, “Drug development”, original article · authors & revision history · CC BY-SA 4.0. Unmodified opening extract, accessed 24 September 2026. This Wikipedia-derived section is provided under CC BY-SA 4.0; the independent MedAtlas notes and design are separate works.

On-site diagram

Drug development · visual study map

Scalable vector illustration. Labeled conceptual map, not a precise anatomical, histological or diagnostic image.
TOPIC LEARNING MAP · NOT AN ANATOMICAL PLATE01 · BackgroundDrug development is the process ofbringing a new pharmaceutical drug tothe market once a lead compound has…02 · Main conceptIt includes preclinical research onmicroorganisms and animals, filing forregulatory status, such as via…03 · Related processThe entire process—from concept throughpreclinical testing in the laboratory toclinical trial development,…04 · Study connectionRead the written explanation directlybelow this visualDrug developmentRead the full text below the visual · all reading is on this website

The wording in this learning map is adapted from the attributed Wikipedia background section below (CC BY-SA 4.0).

Study foundation 01

What the underlying subject studies

At postgraduate and higher-specialty level, begin with normal anatomy and physiology of the relevant organ system, then compare distinct disease mechanisms, their evidence base and the limitations of available investigations.

Study foundation 02

How mechanisms and evidence connect

Advanced study requires evidence appraisal, multidisciplinary interpretation and a clear distinction between established facts, hypotheses and research findings. Procedural, diagnostic and prescribing skills must be learned under an accredited program.

Study foundation 03

How to develop a sound explanation

Identify the scope of this topic within the named specialty, connect it to the applicable patient population and formulate a structured question that can be answered using current specialty literature and supervised teaching.

References and verification (optional)

All reading material on this page appears above. The links below are for checking the primary syllabus, research or source attribution, not requirements for opening this lesson.

NBEMS DNB broad-specialty curricula ↗

Find research on Drug development ↗